xyzal 0.5 mg/ml oral solution
ltt pharma limited - levocetirizine dihydrochloride - oral solution - 0.5 milligram(s)/millilitre - piperazine derivatives; levocetirizine
oxycodone hydrochloride rowex 5 mg hard capsules
rowex ltd - oxycodone hydrochloride - capsule, hard - 5 milligram(s) - natural opium alkaloids; oxycodone
oxycodone hydrochloride rowex 10 mg hard capsules
rowex ltd - oxycodone hydrochloride - capsule, hard - 10 milligram(s) - natural opium alkaloids; oxycodone
oxycodone hydrochloride rowex 20 mg hard capsules
rowex ltd - oxycodone hydrochloride - capsule, hard - 20 milligram(s) - natural opium alkaloids; oxycodone
ertapenem for injection powder for solution
juno pharmaceuticals corp. - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g - carbapenems
ertapenem for injection powder for solution
fresenius kabi canada ltd - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g - carbapenems
ertapenem for injection powder for solution
hikma canada limited - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g - carbapenems
ertapenem for injection powder for solution
dr reddy's laboratories ltd - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g - carbapenems
arcoxia
merck sharp & dohme australia pty ltd - etoricoxib -
arcoxia
organon (new zealand) limited - etoricoxib 120mg; etoricoxib 120mg - film coated tablet - 120 mg - active: etoricoxib 120mg excipient: calcium hydrogen phosphate carnauba wax croscarmellose sodium magnesium stearate microcrystalline cellulose opadry green 39k11529 purified water active: etoricoxib 120mg excipient: calcium hydrogen phosphate dihydrate carnauba wax croscarmellose sodium magnesium stearate microcrystalline cellulose opadry green 39k11529 purified water - arcoxia is indicated for: · acute and chronic treatment of the signs and symptoms of osteoarthritis (oa) and rheumatoid arthritis (ra) · the management of ankylosing spondylitis (as) · treatment of acute gouty arthritis · relief of acute pain, including pain related to minor dental procedures · relief of chronic musculoskeletal pain the decision to prescribe a selective cox-2 inhibitor should only be made: · if non-pharmacological interventions and simple analgesic therapy i.e.paracetamol have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient; and · after assessment of the individual patient's overall risk factors for developing severe adverse events e.g. history of cardiovascular, renal or gastrointestinal disease.